News Conference News TVT 2017 Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base Michael O'Riordan June 17, 2017
News Conference News SCAI 2017 Bioresorbable Scaffolds: Where Do We Go From Here? L.A. McKeown May 15, 2017
News Daily News Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe Michael O'Riordan September 20, 2016
News Daily News Medtronic Warns of Vascular Trauma, Some Resulting in Death, With CoreValve’s EnVeo R Delivery Catheter Michael O'Riordan August 18, 2016
News Daily News FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients Yael L. Maxwell August 18, 2016
News Conference News TVT 2016 Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes Michael O'Riordan June 16, 2016
News Conference News TCT 2015 Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award October 12, 2015
News Daily News Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years July 07, 2015
News Daily News Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery Caitlin E. Cox June 15, 2015